Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-III

Conditions:   COVID-19;   Symptoms and Signs;   COVID-19 Pandemic;   Coronavirus Disease 2019;   Coronavirus Infections Interventions:   Combination Product: Chlorpheniramine Maleate 0.4% Nasal Spray;   Combination Product: Placebo Sponsors:   Dr. Ferrer BioPharma;   Hospital CEMESA Cortés, San Pedro Sula, Honduras Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials